Menu
Brazil’s health regulatory agency Anvisa has opened an investigation into 13 notifications of suspected non-arteritic anterior ischemic optic neuropathy, known as NAION,...
Patients who took the diabetes and obesity drug semaglutide experienced nearly 40 percent fewer asthma attacks, according to research presented on September...
Patients diagnosed with bipolar disorder who took semaglutide recorded a 21 percent lower risk of psychiatric hospitalization compared with periods without the...
La cellula cerebrale considerata un ostacolo alla perdita di peso può, infatti, essere essenziale per il mantenimento di questo processo. Questa scoperta,...
The brain cell considered an obstacle to weight loss may, in fact, be essential for maintaining this process. This discovery, released on...
Le segnalazioni di utilizzatori di farmaci per la perdita di peso, come Ozempic, Wegovy e Mounjaro, hanno sollevato un problema scomodo: lo...
Reports from users of weight loss medications, such as Ozempic, Wegovy and Mounjaro, have raised an uncomfortable issue: the development of bad...
Recenti ricerche hanno rivelato che il farmaco Ozempic (semaglutide), ampiamente noto per il suo utilizzo nel trattamento del diabete di tipo 2...
Recent research has revealed that the drug Ozempic (semaglutide), widely known for its use in the treatment of type 2 diabetes and...
Nieuw onderzoek heeft aangetoond dat afslankhokken, die aanvankelijk bekend stonden om het onder controle houden van diabetes type 2 en obesitas, een...
Sua privacidade
O Mix Vale usa cookies para medir audiência e exibir anúncios que sustentam a redação. Você escolhe. Saiba mais.